Position in IMCR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,287,966
-$807,248 QoQ
Shares Held
103,558
-23.8% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 136 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026TD Asset Management Inc holds $1,129,937,988 across 119 Biotechnology names. IMCR ranks #60 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
259,317 | $161,694,522 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
207,960 | $103,299,970 | |
| 3 | HALO |
Halozyme Therapeutics, Inc.
|
1,115,730 | $87,328,187 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,696 | $70,349,506 | |
| 5 | CYTK |
Cytokinetics Inc
|
385,130 | $32,809,224 | |
| 6 | RPRX |
Royalty Pharma plc
|
567,497 | $31,819,556 | |
| 7 | ASND |
Ascendis Pharma A/S
|
119,085 | $31,762,351 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
272,900 | $31,293,443 |
All Filings in IMCR
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,287,966 | 103,558 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,095,214 | 135,828 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,161,838 | 292,764 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $10,494,283 | 288,860 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,982,964 | 286,264 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $8,777,988 | 295,854 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $9,365,542 | 317,476 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $9,742,195 | 312,952 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $8,977,325 | 264,896 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $13,975,910 | 215,014 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $23,702,257 | 346,930 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $15,669,648 | 301,920 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $8,624,286 | 143,834 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,758,748 | 96,253 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,302,145 | 92,906 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,774,257 | 80,406 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,026,248 | 27,506 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $822,429 | 27,506 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $941,805 | 27,506 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,019,647 | 27,506 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,074,109 | 27,506 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,170,930 | 27,506 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||